Use of dabigatran for treatment of left ventricular thrombus: A tertiary care center experience

OBJECTIVES: Direct oral anticoagulants (DOACs) are now replacing vitamin K oral anticoagulants (VKAs) owing to superior efficacy, rapid action, less bleeding, wider therapeutic range,and fewer food and drug interactions.Unfortunately, the available data on the use of DOACs, particularly dabigatran,...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Bhupendra, Singh, Amrita, Kumar, Manu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753807/
https://www.ncbi.nlm.nih.gov/pubmed/31548950
http://dx.doi.org/10.4103/jfmpc.jfmpc_459_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753807/
https://www.ncbi.nlm.nih.gov/pubmed/31548950
http://dx.doi.org/10.4103/jfmpc.jfmpc_459_19

Ejemplares similares